Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses
- 1 February 1996
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 64 (2), 209-217
- https://doi.org/10.1016/0165-5728(95)00180-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.The Journal of Experimental Medicine, 1993
- T suppressor hybridomas and interleukin‐2‐dependent lines induced by copolymer 1 or by spinal cord homogenate down‐regulate experimental allergic encephalomyelitisEuropean Journal of Immunology, 1993
- Peptide competition for antigen presentationImmunology Today, 1990
- Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell SrfacesInternational Immunology, 1990
- A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple SclerosisNew England Journal of Medicine, 1987
- Chronic experimental allergic encephalomyelitis produced by bovine proteolipid apoprotein: Immunological studies in rabbitsAnnals of Neurology, 1983
- Suppression of experimental allergic encephalomyelitis in rhesus monkeys by a synthetic basic copolymerClinical Immunology and Immunopathology, 1974
- In vivo and in vitro immunological cross‐reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitisEuropean Journal of Immunology, 1973
- Suppression of experimental allergic encephalomyelitis by a synthetic polypeptideEuropean Journal of Immunology, 1971
- Automated Synthesis of PeptidesScience, 1965